Our primary goals as an organization are achieved through adhering to our core values of vision, empathy, sustainability and tenacious teamwork in pursuit of our clients’ interests.
Exclusive Financial Advisor
Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD acquired by BioNTech
Lead Left Bookrunner
Initial Public Offering
Sole Placement Agent
Myriad myPath acquired by Castle Biosciences (NASDAQ: CSTL)
Myriad Rules Based Medicine acquired by Q2 Solutions